Comparison of deep wound infection rates using a synthetic dural substitute (neuropatch) or pericranium graft for dural closure: A clinical review of 1 year

被引:109
作者
Malliti, M
Page, P
Gury, C
Chomette, E
Nataf, F
Roux, FX
机构
[1] St Anna Hosp, Dept Neurosurg, F-75014 Paris, France
[2] St Anna Hosp, Dept Pathol, Paris, France
[3] St Anna Hosp, Dept Med Informat, Paris, France
关键词
dural substitute; neuro-patch; pericranium graft; postsurgical site infections;
D O I
10.1227/01.NEU.0000108640.45371.1A
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
OBJECTIVE: The need to repair dural defects has prompted the use of dura mater substitutes. Many synthetic materials have been used for dural closure. Neuro-Patch (B. Braun Medical S.A., Boulogne, France) is a nonabsorbable microporous fleece composed of polyester urethane that has been approved for human use by the European Union since 1995. To the best of our knowledge, no clinical series with Neuro-Patch have been published thus far, particularly with regard to septic complications. The aim of our study was to compare the safety of Neuro-Patch with that of pericranium graft with regard to postoperative wound infections. METHODS: This is a retrospective study of 1 year's experience including all patients who underwent dural plasty with a Neuro-Patch (n = 61) or pericranium graft (n = 63). The follow-up period was at least 12 months after surgery. Before wound infection rates in the two groups were compared, factors suspected of being risks for neurosurgical site infection were evaluated. RESULTS: Patient characteristics (mean age, neurological diagnosis), surgical procedures, prophylactic antibiotics, and risk factors for surgical infections (including duration of surgery, emergency, contaminated operations, and external cerebrospinal fluid drainage) were similar in the Neuro-Patch and pericranium groups. Deep wound infection rates in the Neuro-Patch and pericranium groups were 15 and 5%, respectively (P = 0.06), and cerebrospinal fluid leaks were significantly more frequent in the Neuro-Patch group (13 versus 1.6%, P < 0.05). CONCLUSION: The results of our investigations show that Neuro-Patch raised the risk of wound infection, as do foreign materials implanted in the body. Synthetic dural grafts should be reserved for when autologous grafts are not sufficient or possible. An extensive prospective multicenter randomized trial is needed to confirm our results.
引用
收藏
页码:599 / 603
页数:5
相关论文
共 21 条
[1]  
*CTR COORD LUTT CO, 1995, GUID DEF INF NOS
[2]   SPONTANEOUS HEMATOMA AS UNUSUAL COMPLICATION OF SILASTIC DURAL SUBSTITUTE - REPORT OF 2 CASES [J].
FONTANA, R ;
TALAMONTI, G ;
DANGELO, V ;
ARENA, O ;
MONTE, V ;
COLLICE, M .
ACTA NEUROCHIRURGICA, 1992, 115 (1-2) :64-66
[3]   COMPLICATIONS TO THE USE OF VICRYL COLLAGEN DURAL SUBSTITUTE [J].
GUDMUNDSSON, G ;
SOGAARD, I .
ACTA NEUROCHIRURGICA, 1995, 132 (1-3) :145-147
[4]   Risk factors for neurosurgical site infections after craniotomy: A prospective multicenter study of 2944 patients [J].
Korinek, AM .
NEUROSURGERY, 1997, 41 (05) :1073-1079
[5]   CREUTZFELDT-JAKOB-DISEASE IN A PREGNANT WOMAN WITH AN IMPLANTED DURA-MATER GRAFT [J].
LANE, KL ;
BROWN, P ;
HOWELL, DN ;
CRAIN, BJ ;
HULETTE, CM ;
BURGER, PC ;
DEARMOND, SJ .
NEUROSURGERY, 1994, 34 (04) :737-739
[6]   RISK-FACTORS FOR POSTOPERATIVE NEUROSURGICAL WOUND-INFECTION - A CASE-CONTROL STUDY [J].
MOLLMAN, HD ;
HAINES, SJ .
JOURNAL OF NEUROSURGERY, 1986, 64 (06) :902-906
[7]   A CLINICOPATHOLOGICAL STUDY OF COLLAGEN SPONGE AS A DURAL GRAFT IN NEUROSURGERY [J].
NAROTAM, PK ;
VANDELLEN, JR ;
BHOOLA, KD .
JOURNAL OF NEUROSURGERY, 1995, 82 (03) :406-412
[8]   Successful treatment of postoperative meningitis due to Haemophilus influenzae without removal of an expanded polytetrafluoroethylene dural graft [J].
Nazzaro, JM ;
Craven, DE .
CLINICAL INFECTIOUS DISEASES, 1998, 26 (02) :516-518
[9]  
PENAR PL, 1987, J NEUROSURG, V67, P149
[10]  
Printzen G., 1996, Injury, V27, pSC9